Failure of traditional trough levels to predict tacrolimus concentrations

Therapeutic Drug Monitoring

Volumn 23, Issue 2, 2001, Pages 129-133

  Macchi Andanson, Magali ^a,b   Charpiat, Bruno ^a,b   Jelliffe, Roger W ^a,b   Ducerf, Christian ^a,b   Fourcade, Nadine ^a,b   Baulieux, Jacques ^a,b  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Optimal design; Population pharmacokinetic; Tacrolimus; Therapeutic drug monitoring

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; BAYES THEOREM; CLINICAL ARTICLE; COMPUTER PROGRAM; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; PREDICTION; PRIORITY JOURNAL; PROBABILITY;

BAYES THEOREM; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MODELS, BIOLOGICAL; TACROLIMUS;

EID: 0035086853     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200104000-00006     Document Type: Article

References (11)

1. Pharmacokinetics and pharmacodynamics of FK506 in pediatric patients receiving living-related donor liver transplantations
2. Evaluation analytique du dosage du tacrolimus (FK 506) dans le sang total sur l'automate d'immunoanalyze IMX Abbott
3. Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis
4. Pharmacokinetics of tacrolimus in liver transplant patients
5. Some suggestions for measuring predictive performance
6. Tacrolimus: An update of its pharmacology and clinical efficacy in the management of organ transplantation
7. Pharmacokinetics of FK506 in living related liver transplantation
8. An evaluation of optimal sampling strategy and adaptive study design
9. Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokinetics
10. Optimal sampling times for pharmacokinetic experiments